Correlation Between Scisparc and GlucoTrack
Can any of the company-specific risk be diversified away by investing in both Scisparc and GlucoTrack at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scisparc and GlucoTrack into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scisparc and GlucoTrack, you can compare the effects of market volatilities on Scisparc and GlucoTrack and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scisparc with a short position of GlucoTrack. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scisparc and GlucoTrack.
Diversification Opportunities for Scisparc and GlucoTrack
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Scisparc and GlucoTrack is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Scisparc and GlucoTrack in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GlucoTrack and Scisparc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scisparc are associated (or correlated) with GlucoTrack. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GlucoTrack has no effect on the direction of Scisparc i.e., Scisparc and GlucoTrack go up and down completely randomly.
Pair Corralation between Scisparc and GlucoTrack
Given the investment horizon of 90 days Scisparc is expected to under-perform the GlucoTrack. But the stock apears to be less risky and, when comparing its historical volatility, Scisparc is 2.34 times less risky than GlucoTrack. The stock trades about -0.1 of its potential returns per unit of risk. The GlucoTrack is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 798.00 in GlucoTrack on May 25, 2025 and sell it today you would lose (245.00) from holding GlucoTrack or give up 30.7% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Scisparc vs. GlucoTrack
Performance |
Timeline |
Scisparc |
GlucoTrack |
Scisparc and GlucoTrack Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Scisparc and GlucoTrack
The main advantage of trading using opposite Scisparc and GlucoTrack positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scisparc position performs unexpectedly, GlucoTrack can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GlucoTrack will offset losses from the drop in GlucoTrack's long position.Scisparc vs. Clearmind Medicine Common | Scisparc vs. Coeptis Therapeutics | Scisparc vs. Quoin Pharmaceuticals Ltd | Scisparc vs. bioAffinity Technologies, |
GlucoTrack vs. Innovative Eyewear | GlucoTrack vs. Sharps Technology | GlucoTrack vs. JIN MEDICAL INTERNATIONAL | GlucoTrack vs. Nexgel Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |